AMPE Research and Charts

AMPE - Ampio Pharmaceuticals Inc (Healthcare: Biotechnology)

Projected Earnings Date: 2024-08-09 (Delayed quote data 2024-12-26)

Last 0.00	Change ⇓ 0.00 (0.00%)	Volume 669
	Open 0.00	High 0.00	Low 0.00

8EMA (Daily) 0.00	40EMA (Daily) 0.01	50EMA (Daily) 0.01	STO (Daily) 0.000	MACD Hist (Daily) 0.000
8EMA (Weekly) 0.006	40EMA (Weekly) 0.73	50EMA (Weekly) 1.89	STO (Weekly) 0.000	MACD Hist (Weekly) 0.180


Company Profile
Ampio Pharmaceuticals Inc is a biopharmaceutical company. It is focused on the development and advancement of immunology-based therapies for prevalent inflammatory conditions. Its lead product candidate, Ampion, is in clinical trials and is being developed for the treatment of severe Osteoarthritis of the Knee, an intravenous treatment for COVID-19 patients, and an inhaled treatment for COVID-19 induced respiratory distress.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.